User menu

FOXO transcription factors in cancer development and therapy.

Bibliographic reference Coomans de Brachène, Alexandra ; Demoulin, Jean-Baptiste. FOXO transcription factors in cancer development and therapy.. In: Cellular and Molecular Life Sciences, Vol. 73, no. 6, p. 1159-1172 (2016)
Permanent URL http://hdl.handle.net/2078.1/169602
  1. Fu Z, Tindall D J, FOXOs, cancer and regulation of apoptosis, 10.1038/onc.2008.24
  2. Anderson Michael J., Viars Carrie S., Czekay Suzanne, Cavenee Webster K., Arden Karen C., Cloning and Characterization of Three Human Forkhead Genes That Comprise an FKHR-like Gene Subfamily, 10.1006/geno.1997.5122
  3. FURUYAMA Tatsuo, NAKAZAWA Toru, NAKANO Itsuko, MORI Nozomu, Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues, 10.1042/bj3490629
  4. Jacobs Frank M. J., van der Heide Lars P., Wijchers Patrick J. E. C., Burbach J. Peter H., Hoekman Marco F. M., Smidt Marten P., FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics, 10.1074/jbc.m302804200
  5. Hosaka T., Biggs W. H., Tieu D., Boyer A. D., Varki N. M., Cavenee W. K., Arden K. C., Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification, 10.1073/pnas.0400093101
  6. Calnan D R, Brunet A, The FoxO code, 10.1038/onc.2008.21
  7. Brunet Anne, Bonni Azad, Zigmond Michael J, Lin Michael Z, Juo Peter, Hu Linda S, Anderson Michael J, Arden Karen C, Blenis John, Greenberg Michael E, Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor, 10.1016/s0092-8674(00)80595-4
  8. van der HEIDE Lars P., HOEKMAN Marco F. M., SMIDT Marten P., The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation, 10.1042/bj20040167
  9. Wang Y, Zhou Y, Graves DT (2014) FOXO transcription factors: their clinical significance and regulation. BioMed Res Int 2014:925350. doi: 10.1155/2014/925350
  10. Essaghir Ahmed, Dif Nicolas, Marbehant Catherine Y., Coffer Paul J., Demoulin Jean-Baptiste, The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors, 10.1074/jbc.m808848200
  11. van der Vos Kristan E., Coffer Paul J., The Extending Network of FOXO Transcriptional Target Genes, 10.1089/ars.2010.3419
  12. Paik Ji-Hye, Kollipara Ramya, Chu Gerald, Ji Hongkai, Xiao Yonghong, Ding Zhihu, Miao Lili, Tothova Zuzana, Horner James W., Carrasco Daniel R., Jiang Shan, Gilliland D. Gary, Chin Lynda, Wong Wing H., Castrillon Diego H., DePinho Ronald A., FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis, 10.1016/j.cell.2006.12.029
  13. Shaw Reuben J., Cantley Lewis C., Ras, PI(3)K and mTOR signalling controls tumour cell growth, 10.1038/nature04869
  14. Kharas M. G., Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells, 10.1182/blood-2003-07-2193
  15. Scheijen Blanca, Ngo Hai T, Kang Hyun, Griffin James D, FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins, 10.1038/sj.onc.1207456
  16. Reagan-Shaw Shannon, Ahmad Nihal, RNA Interference–Mediated Depletion of Phosphoinositide 3-Kinase Activates Forkhead Box Class O Transcription Factors and Induces Cell Cycle Arrest and Apoptosis in Breast Carcinoma Cells, 10.1158/0008-5472.can-05-1018
  17. Prasad Shyam Babu, Yadav Suresh Singh, Das Mitali, Govardhan H. B., Pandey Lakshmi Kant, Singh Sunita, Pradhan Satyajit, Narayan Gopeshwar, Down Regulation of FOXO1 Promotes Cell Proliferation in Cervical Cancer, 10.7150/jca.6554
  18. Kelly-Spratt K S, Philipp-Staheli J, Gurley K E, Hoon-Kim K, Knoblaugh S, Kemp C J, Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer, 10.1038/onc.2009.226
  19. Weidinger Carl, Krause Kerstin, Mueller Kathrin, Klagge Antje, Fuhrer Dagmar, FOXO3 Is Inhibited by Oncogenic PI3K/Akt Signaling but Can Be Reactivated by the NSAID Sulindac Sulfide, 10.1210/jc.2010-2453
  20. Xie L., Ushmorov A., Leithauser F., Guan H., Steidl C., Farbinger J., Pelzer C., Vogel M. J., Maier H. J., Gascoyne R. D., Moller P., Wirth T., FOXO1 is a tumor suppressor in classical Hodgkin lymphoma, 10.1182/blood-2011-09-381905
  21. Yang Jer-Yen, Zong Cong S., Xia Weiya, Yamaguchi Hirohito, Ding Qingqing, Xie Xiaoming, Lang Jing-Yu, Lai Chien-Chen, Chang Chun-Ju, Huang Wei-Chien, Huang Hsin, Kuo Hsu-Ping, Lee Dung-Fang, Li Long-Yuan, Lien Huang-Chun, Cheng Xiaoyun, Chang King-Jen, Hsiao Chwan-Deng, Tsai Fuu-Jen, Tsai Chang-Hai, Sahin Aysegul A., Muller William J., Mills Gordon B., Yu Dihua, Hortobagyi Gabriel N., Hung Mien-Chie, ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation, 10.1038/ncb1676
  22. Sunayama J, Sato A, Matsuda K, Tachibana K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C (2011) FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Stem Cells 29(9):1327–1337. doi: 10.1002/stem.696
  23. Hu Mickey C.-T, Lee Dung-Fang, Xia Weiya, Golfman Leonard S, Ou-Yang Fu, Yang Jer-Yen, Zou Yiyu, Bao Shilai, Hanada Norihisa, Saso Hitomi, Kobayashi Ryuji, Hung Mien-Chie, IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a, 10.1016/s0092-8674(04)00302-2
  24. Chapuis N., Park S., Leotoing L., Tamburini J., Verdier F., Bardet V., Green A. S., Willems L., Agou F., Ifrah N., Dreyfus F., Bismuth G., Baud V., Lacombe C., Mayeux P., Bouscary D., I B kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia, 10.1182/blood-2009-12-260711
  25. Guo Jian-Ping, Tian Wei, Shu Shaokun, Xin Yu, Shou Chengchao, Cheng Jin Q., IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function, 10.1371/journal.pone.0063636
  26. Lin Huanxin, Dai Ting, Xiong Huaping, Zhao Xiaohui, Chen Xiuting, Yu Chunping, Li Jun, Wang Xi, Song Libing, Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a, 10.1371/journal.pone.0015797
  27. Guo Y, Liu H, Zhang H, Shang C, Song Y (2012) miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer. Oncol Lett 4(3):561–565. doi: 10.3892/ol.2012.775
  28. Segura Miguel F., Hanniford Douglas, Menendez Silvia, Reavie Linsey, Zou Xuanyi, Alvarez-Diaz Silvia, Zakrzewski Jan, Blochin Elen, Rose Amy, Bogunovic Dusan, Polsky David, Wei Jianjun, Lee Peng, Belitskaya-Levy Ilana, Bhardwaj Nina, Osman Iman, Hernando Eva, Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor, 10.1073/pnas.0808263106
  29. Guttilla Irene K., White Bruce A., Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells, 10.1074/jbc.m109.031427
  30. Myatt S. S., Wang J., Monteiro L. J., Christian M., Ho K.-K., Fusi L., Dina R. E., Brosens J. J., Ghaem-Maghami S., Lam E. W-F., Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer, 10.1158/0008-5472.can-09-1891
  31. Wu Ziqing, Sun Huabin, Zeng Weixia, He Jincan, Mao Xiangming, Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1, 10.1371/journal.pone.0045825
  32. Pei H, Jin Z, Chen S, Sun X, Yu J, Guo W (2014) MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1. Mol Cell Biochem. doi: 10.1007/s11010-014-2281-2
  33. Yang Xue-Wei, Shen Guan-Zhu, Cao Liang-Qi, Jiang Xiao-Feng, Peng He-Ping, Shen Gang, Chen De, Xue Ping, MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1, 10.1186/1471-2407-14-909
  34. Zhao Z, Qin L, Li S (2015) miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1. Tumour Biol J Int Soc Oncodev Biol Med. doi: 10.1007/s13277-015-4425-8
  35. Ho K K, Myatt S S, Lam E W-F, Many forks in the path: cycling with FoxO, 10.1038/onc.2008.23
  36. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place R F, Pookot D, Majid S, Igawa M, Dahiya R, Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity, 10.1038/sj.onc.1210572
  37. Shiota M., Song Y., Yokomizo A., Kiyoshima K., Tada Y., Uchino H., Uchiumi T., Inokuchi J., Oda Y., Kuroiwa K., Tatsugami K., Naito S., Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box-Binding Protein 1, and E-Cadherin Regulation, 10.1158/1078-0432.ccr-10-0376
  38. Su Bing, Gao Lingqiu, Baranowski Catherine, Gillard Bryan, Wang Jianmin, Ransom Ryan, Ko Hyun-Kyung, Gelman Irwin H., A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer, 10.1371/journal.pone.0101411
  39. Zhang H., Pan Y., Zheng L., Choe C., Lindgren B., Jensen E. D., Westendorf J. J., Cheng L., Huang H., FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion, 10.1158/0008-5472.can-10-2603
  40. Courtois-Cox Stéphanie, Genther Williams Sybil M., Reczek Elizabeth E., Johnson Bryan W., McGillicuddy Lauren T., Johannessen Cory M., Hollstein Pablo E., MacCollin Mia, Cichowski Karen, A negative feedback signaling network underlies oncogene-induced senescence, 10.1016/j.ccr.2006.10.003
  41. de Keizer P. L. J., Packer L. M., Szypowska A. A., Riedl-Polderman P. E., van den Broek N. J. F., de Bruin A., Dansen T. B., Marais R., Brenkman A. B., Burgering B. M. T., Activation of Forkhead Box O Transcription Factors by Oncogenic BRAF Promotes p21cip1-Dependent Senescence, 10.1158/0008-5472.can-10-1563
  42. Yoo SY, Kwon SM (2013) Angiogenesis and its therapeutic opportunities. Mediators Inflamm 2013:127170. doi: 10.1155/2013/127170
  43. Furuyama Tatsuo, Kitayama Kazuko, Shimoda Yuri, Ogawa Minetaro, Sone Kiyoaki, Yoshida-Araki Kiyomi, Hisatsune Hiroshi, Nishikawa Shin-ichi, Nakayama Keiko, Nakayama Keiichi, Ikeda Kyoji, Motoyama Noboru, Mori Nozomu, Abnormal Angiogenesis inFoxo1(Fkhr)-deficient Mice, 10.1074/jbc.m314214200
  44. Abid Md. Ruhul, Shih Shu-Ching, Otu Hasan H., Spokes Katherine C., Okada Yoshiaki, Curiel David T., Minami Takashi, Aird William C., A Novel Class of Vascular Endothelial Growth Factor-responsive Genes That Require Forkhead Activity for Expression, 10.1074/jbc.m608620200
  45. Daly C., Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1), 10.1101/gad.1189704
  46. Potente Michael, Urbich Carmen, Sasaki Ken-ichiro, Hofmann Wolf K., Heeschen Christopher, Aicher Alexandra, Kollipara Ramya, DePinho Ronald A., Zeiher Andreas M., Dimmeler Stefanie, Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization, 10.1172/jci23126
  47. Kim Sue Youn, Yoon Jiyeon, Ko Young San, Chang Mee Soo, Park Jong-Wan, Lee Hee Eun, Kim Min A, Kim Ji Hun, Kim Woo Ho, Lee Byung Lan, Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules, 10.1186/1471-2407-11-264
  48. Yalcin Safak, Marinkovic Dragan, Mungamuri Sathish Kumar, Zhang Xin, Tong Wei, Sellers Rani, Ghaffari Saghi, ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice, 10.1038/emboj.2010.292
  49. Tothova Zuzana, Kollipara Ramya, Huntly Brian J., Lee Benjamin H., Castrillon Diego H., Cullen Dana E., McDowell Elizabeth P., Lazo-Kallanian Suzan, Williams Ifor R., Sears Christopher, Armstrong Scott A., Passegué Emmanuelle, DePinho Ronald A., Gilliland D. Gary, FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress, 10.1016/j.cell.2007.01.003
  50. Zhao Ying, Yang Jing, Liao Wenjuan, Liu Xiangyu, Zhang Hui, Wang Shan, Wang Donglai, Feng Jingnan, Yu Li, Zhu Wei-Guo, Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity, 10.1038/ncb2069
  51. Wang Feng, Marshall Christopher B., Yamamoto Kazuo, Li Guang-Yao, Plevin Michael J., You Han, Mak Tak W., Ikura Mitsuhiko, Biochemical and Structural Characterization of an Intramolecular Interaction in FOXO3a and Its Binding with p53, 10.1016/j.jmb.2008.09.025
  52. You H., Yamamoto K., Mak T. W., Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a, 10.1073/pnas.0600889103
  53. Bouchard C., Lee S., Paulus-Hock V., Loddenkemper C., Eilers M., Schmitt C. A., FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf, 10.1101/gad.453107
  54. Renault V M, Thekkat P U, Hoang K L, White J L, Brady C A, Kenzelmann Broz D, Venturelli O S, Johnson T M, Oskoui P R, Xuan Z, Santo E E, Zhang M Q, Vogel H, Attardi L D, Brunet A, The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor, 10.1038/onc.2011.35
  55. Galili Naomi, Davis Richard J., Fredericks William J., Mukhopadhyay Sunil, Rauscher Frank J., Emanuel Beverly S., Rovera Giovanni, Barr Frederic G., Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma, 10.1038/ng1193-230
  56. Davis RJ, D’Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54(11):2869–2872
  57. Xia Shujuan J., Holder Dara D., Pawel Bruce R., Zhang Chune, Barr Frederic G., High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human Myoblasts, 10.2353/ajpath.2009.090192
  58. Linardic Corinne M., PAX3–FOXO1 fusion gene in rhabdomyosarcoma, 10.1016/j.canlet.2008.03.035
  59. Mercado Gabriela E., Xia Shujuan J., Zhang Chune, Ahn Eun Hyun, Gustafson Donna M., Laé Marick, Ladanyi Marc, Barr Frederic G., Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus onMYCN as a biologically relevant target, 10.1002/gcc.20554
  60. Lagutina I., Conway S. J., Sublett J., Grosveld G. C., Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors, 10.1128/mcb.22.20.7204-7216.2002
  61. Keller C., Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function, 10.1101/gad.1244004
  62. Fredericks W J, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr F G, Rauscher F J, The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3., 10.1128/mcb.15.3.1522
  63. Borkhardt Arndt, Repp Reinald, Haas Oskar A, Leis Thomas, Harbott Jochen, Kreuder Joachim, Hammermann Jutta, Henn Traudl, Lampert Fritz, Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23), 10.1038/sj.onc.1200814
  64. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA (1997) AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90(9):3714–3719
  65. Dobson Claire L., Warren Alan J., Pannell Richard, Forster Alan, Rabbitts Terence H., Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene, 10.1093/emboj/19.5.843
  66. So C. W., Cleary M. L., MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function, 10.1128/mcb.22.18.6542-6552.2002
  67. So C. W., Common mechanism for oncogenic activation of MLL by forkhead family proteins, 10.1182/blood-2002-06-1785
  68. Sugita Shintaro, Arai Yasuhito, Tonooka Akiko, Hama Natsuko, Totoki Yasushi, Fujii Tomoki, Aoyama Tomoyuki, Asanuma Hiroko, Tsukahara Tomohide, Kaya Mitsunori, Shibata Tatsuhiro, Hasegawa Tadashi, A Novel CIC-FOXO4 Gene Fusion in Undifferentiated Small Round Cell Sarcoma : A Genetically Distinct Variant of Ewing-like Sarcoma, 10.1097/pas.0000000000000286
  69. Solomon David A., Brohl Andrew S., Khan Javed, Miettinen Markku, Clinicopathologic Features of a Second Patient With Ewing-like Sarcoma Harboring CIC-FOXO4 Gene Fusion : , 10.1097/pas.0000000000000335
  70. Morin Ryan D., Mendez-Lago Maria, Mungall Andrew J., Goya Rodrigo, Mungall Karen L., Corbett Richard D., Johnson Nathalie A., Severson Tesa M., Chiu Readman, Field Matthew, Jackman Shaun, Krzywinski Martin, Scott David W., Trinh Diane L., Tamura-Wells Jessica, Li Sa, Firme Marlo R., Rogic Sanja, Griffith Malachi, Chan Susanna, Yakovenko Oleksandr, Meyer Irmtraud M., Zhao Eric Y., Smailus Duane, Moksa Michelle, Chittaranjan Suganthi, Rimsza Lisa, Brooks-Wilson Angela, Spinelli John J., Ben-Neriah Susana, Meissner Barbara, Woolcock Bruce, Boyle Merrill, McDonald Helen, Tam Angela, Zhao Yongjun, Delaney Allen, Zeng Thomas, Tse Kane, Butterfield Yaron, Birol Inanç, Holt Rob, Schein Jacqueline, Horsman Douglas E., Moore Richard, Jones Steven J. M., Connors Joseph M., Hirst Martin, Gascoyne Randy D., Marra Marco A., Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma, 10.1038/nature10351
  71. Trinh D. L., Scott D. W., Morin R. D., Mendez-Lago M., An J., Jones S. J. M., Mungall A. J., Zhao Y., Schein J., Steidl C., Connors J. M., Gascoyne R. D., Marra M. A., Analysis of FOXO1 mutations in diffuse large B-cell lymphoma, 10.1182/blood-2013-01-479865
  72. Pellicano Francesca, Scott Mary T., Helgason G. Vignir, Hopcroft Lisa E. M., Allan Elaine K., Aspinall-O'Dea Mark, Copland Mhairi, Pierce Andrew, Huntly Brian J. P., Whetton Anthony D., Holyoake Tessa L., The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors : FOXO Activity in CML Progenitor Cells, 10.1002/stem.1748
  73. Naka Kazuhito, Hoshii Takayuki, Muraguchi Teruyuki, Tadokoro Yuko, Ooshio Takako, Kondo Yukio, Nakao Shinji, Motoyama Noboru, Hirao Atsushi, TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia, 10.1038/nature08734
  74. Hurtz Christian, Hatzi Katerina, Cerchietti Leandro, Braig Melanie, Park Eugene, Kim Yong-mi, Herzog Sebastian, Ramezani-Rad Parham, Jumaa Hassan, Müller Martin C., Hofmann Wolf-Karsten, Hochhaus Andreas, Ye B. Hilda, Agarwal Anupriya, Druker Brian J., Shah Neil P., Melnick Ari M., Müschen Markus, BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia, 10.1084/jem.20110304
  75. Sykes Stephen M., Lane Steven W., Bullinger Lars, Kalaitzidis Demetrios, Yusuf Rushdia, Saez Borja, Ferraro Francesca, Mercier Francois, Singh Harshabad, Brumme Kristina M., Acharya Sanket S., Scholl Claudia, Tothova Zuzana, Attar Eyal C., Fröhling Stefan, DePinho Ronald A., Gilliland D. Gary, Armstrong Scott A., Scadden David T., AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias, 10.1016/j.cell.2011.07.032
  76. Santamaría Carlos M., Chillón Maria C., García-Sanz Ramón, Pérez Cristina, Caballero María D., Ramos Fernando, de Coca Alfonso García, Alonso José M., Giraldo Pilar, Bernal Teresa, Queizán José A., Rodriguez Juan N., Fernández-Abellán Pascual, Bárez Abelardo, Peñarrubia María J., Vidriales María B., Balanzategui Ana, Sarasquete María E., Alcoceba Miguel, Díaz-Mediavilla Joaquín, San Miguel Jesús F., Gonzalez Marcos, High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics, 10.1016/j.leukres.2009.04.024
  77. Gargini Ricardo, Cerliani Juan P., Escoll Maribel, Antón Inés M., Wandosell Francisco, Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway : Akt/FoxO/Bim regulates Cancer Stem Cells Phenotype, 10.1002/stem.1904
  78. Smit L, Berns K, Spence K, Ryder WD, Zeps N, Madiredjo M, Beijersbergen R, Bernards R, Clarke RB (2015) An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation. Oncotarget. doi: 10.18632/oncotarget.6354
  79. Prabhu V. V., Allen J. E., Dicker D. T., El-Deiry W. S., Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner, 10.1158/0008-5472.can-13-3451
  80. Tenbaum Stephan P, Ordóñez-Morán Paloma, Puig Isabel, Chicote Irene, Arqués Oriol, Landolfi Stefania, Fernández Yolanda, Herance José Raúl, Gispert Juan D, Mendizabal Leire, Aguilar Susana, Cajal Santiago Ramón y, Schwartz Simó, Vivancos Ana, Espín Eloy, Rojas Santiago, Baselga José, Tabernero Josep, Muñoz Alberto, Palmer Héctor G, β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer, 10.1038/nm.2772
  81. Arques O, Chicote I, Puig I, Tenbaum SP, Argiles G, Dienstmann R, Fernandez N, Caratu G, Matito J, Silberschmidt D, Rodon J, Landolfi S, Prat A, Espin E, Charco R, Nuciforo P, Vivancos A, Shao W, Tabernero J, Palmer HG (2015) Tankyrase inhibition blocks Wnt/beta-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res. doi: 10.1158/1078-0432.CCR-14-3081
  82. Sisci Diego, Maris Pamela, Grazia Cesario Maria, Anselmo Wanda, Coroniti Roberta, Elvi Trombino Giovanna, Romeo Francesco, Ferraro Aurora, Lanzino Marilena, Aquila Saveria, Maggiolini Marcello, Mauro Loredana, Morelli Catia, Andò Sebastiano, The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness, 10.4161/cc.26421
  83. Storz P., Doppler H., Copland J. A., Simpson K. J., Toker A., FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases, 10.1128/mcb.00077-09
  84. Feng X., Wu Z., Wu Y., Hankey W., Prior T. W., Li L., Ganju R. K., Shen R., Zou X., Cdc25A Regulates Matrix Metalloprotease 1 through Foxo1 and Mediates Metastasis of Breast Cancer Cells, 10.1128/mcb.05523-11
  85. Li Y, Yu J, Du D, Fu S, Chen Y, Yu F, Gao P (2013) Involvement of post-transcriptional regulation of FOXO1 by HuR in 5-FU-induced apoptosis in breast cancer cells. Oncol Lett 6(1):156–160. doi: 10.3892/ol.2013.1352
  86. Sunters Andrew, Fernández de Mattos Silvia, Stahl Marie, Brosens Jan J., Zoumpoulidou Georgia, Saunders Catherine A., Coffer Paul J., Medema René H., Coombes R. Charles, Lam Eric W.-F., FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines, 10.1074/jbc.m309523200
  87. Essafi Abdelkader, Fernández de Mattos Silvia, Hassen Yasmin AM, Soeiro Inês, Mufti Ghulam J, Thomas N Shaun B, Medema René H, Lam Eric W-F, Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells, 10.1038/sj.onc.1208421
  88. Yang Jer-Yen, Hung Mien-Chie, Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy, 10.2174/138945011796150299
  89. Chen Qinghe, Ganapathy Suthakar, Singh Karan P., Shankar Sharmila, Srivastava Rakesh K., Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells, 10.1371/journal.pone.0015288
  90. Roy Sanjit K, Srivastava Rakesh K, Shankar Sharmila, Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer, 10.1186/1750-2187-5-10
  91. Valis K., Prochazka L., Boura E., Chladova J., Obsil T., Rohlena J., Truksa J., Dong L.-F., Ralph S. J., Neuzil J., Hippo/Mst1 Stimulates Transcription of the Proapoptotic Mediator NOXA in a FoxO1-Dependent Manner, 10.1158/0008-5472.can-10-2203
  92. Han C.-Y., Cho K.-B., Choi H.-S., Han H.-K., Kang K.-W., Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells, 10.1093/carcin/bgn092
  93. Hui R. C-Y., Francis R. E., Guest S. K., Costa J. R., Gomes A. R., Myatt S. S., Brosens J. J., Lam E. W-F., Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells, 10.1158/1535-7163.mct-07-0397
  94. Hui R. C.-Y., Gomes A. R., Constantinidou D., Costa J. R., Karadedou C. T., Fernandez de Mattos S., Wymann M. P., Brosens J. J., Schulze A., Lam E. W.-F., The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression, 10.1128/mcb.01265-07
  95. Chandarlapaty Sarat, Sawai Ayana, Scaltriti Maurizio, Rodrik-Outmezguine Vanessa, Grbovic-Huezo Olivera, Serra Violeta, Majumder Pradip K., Baselga Jose, Rosen Neal, AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity, 10.1016/j.ccr.2010.10.031
  96. Lin A, Piao HL, Zhuang L, Sarbassov DD, Ma L, Gan B (2014) FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacological inhibition of the PI3K-AKT pathway. Cancer Res. doi: 10.1158/0008-5472.CAN-13-1729
  97. Ramanathan Balakrishnan, Jan Kun-Yan, Chen Chien-Hung, Hour Tzyh-Chyuan, Yu Hong-Jen, Pu Yeong-Shiau, Resistance to Paclitaxel Is Proportional to Cellular Total Antioxidant Capacity, 10.1158/0008-5472.can-05-1162
  98. Goto T, Takano M, Hirata J, Tsuda H, The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers, 10.1038/sj.bjc.6604279
  99. Asada Sachie, Daitoku Hiroaki, Matsuzaki Hitomi, Saito Tomoko, Sudo Tatsuhiko, Mukai Hidehito, Iwashita Shintaro, Kako Koichiro, Kishi Tsutomu, Kasuya Yoshitoshi, Fukamizu Akiyoshi, Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1, 10.1016/j.cellsig.2006.08.015
  100. Matkar Smita, Sharma Paras, Gao Shubin, Gurung Buddha, Katona Bryson W., Liao Jennifer, Muhammad Abdul Bari, Kong Xiang-Cheng, Wang Lei, Jin Guanghui, Dang Chi V., Hua Xianxin, An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis, 10.1016/j.ccell.2015.09.005
  101. Wang Wei, Li Nan-Nan, Du Yan, Lv Fei-Fei, Lin Guo-Qiang, FoxO3a and nilotinib-induced erythroid differentiation of CML-BC cells, 10.1016/j.leukres.2013.07.001
  102. Szydlowski M, Kiliszek P, Sewastianik T, Jablonska E, Bialopiotrowicz E, Gorniak P, Polak A, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Szumera-Cieckiewicz A, Malenda A, Lech-Maranda E, Warzocha K, Juszczynski P (2015) FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas. Blood. doi: 10.1182/blood-2015-06-654111